AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimatica-M1 Tablet

Prescription Icon
Prescription Required

Marketer

Almatica Pharmaceuticals Private Limited

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimatica-M1 Tablet

Metformin-Linagliptin combination tablets are categorized as antidiabetic medications. This dual-drug formulation manages type 2 diabetes in adults by regulating blood glucose. Administer this medication with meals, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continuous use is crucial, even with controlled blood sugar, as discontinuation without medical supervision can lead to elevated glucose, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. This medication is a component of a comprehensive diabetes management plan that must include a healthy diet, regular exercise, and weight management as directed by your healthcare provider. Lifestyle modifications are key to diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Regular meals and readily available fast-acting glucose sources (e.g., sugary snacks or juice) are essential preventative measures. Alcohol consumption elevates hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your doctor before commencing treatment. Pregnant or lactating individuals must consult their physician. Regular blood glucose monitoring and periodic blood tests (to assess blood cell counts and liver function) are necessary.

Primary Ingredients of Glimatica-M1 Tablet

No text was provided. Please provide the text you want me to rephrase.

Uses of Glimatica-M1 Tablet

Managing type 2 diabetes

Major Benefits of Glimatica-M1 Tablet:

Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Glimatica-M1 Tablet with a meal.

Common Side effects of Glimatica-M1 Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimatica-M1 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimatica-M1 Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with food.

How Glimatica-M1 Tablet works:

Glimatica-M1 tablets contain glimepiride and metformin, two medications that manage blood sugar. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol concurrently with Glimatica-M1 Tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimatica-M1 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Lactation and Glimatica-M1 tablets are incompatible. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Impaired driving is possible with excessively low or high blood sugar levels. Refrain from driving if you experience such symptoms.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimatica-M1 tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Glimatica-M1 use. Physician consultation is advised. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimatica-M1 Tablets cautiously, potentially requiring dosage modification. Consult a physician. For those with mild to moderate liver disease, initiation should be at a low dose; it's contraindicated in patients with severe liver dysfunction.

What if you forget to take Glimatica-M1 Tablet :

Should you forget a Glimatica-M1 Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimatica-M1 Tablet

LabelValue
Potential for Dependence None.
Type of Treatment Medication for diabetes

FAQs on Glimatica-M1 Tablet

Maintain this medication within its original, securely sealed container. Follow the storage guidelines provided on the packaging. Discard any leftover medication. Prevent access by children, pets, and others.
Glimatica-M1 Tablets may cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare but potentially harmful side effect is more likely in individuals with kidney impairment, the elderly, or those who consume significant amounts of alcohol. Symptoms can include muscle aches or weakness, lightheadedness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. Should these symptoms arise, discontinue Glimatica-M1 Tablet use and seek immediate medical attention.
Glimatica-M1 tablets contain a dual-action formulation of glimepiride and metformin, indicated for managing type 2 diabetes mellitus in adults. This medication enhances glycemic control when coupled with a suitable diet and exercise regimen. Glimepiride's mechanism involves stimulating pancreatic insulin secretion, thereby reducing blood glucose. Metformin acts by decreasing hepatic glucose output and increasing insulin responsiveness. This combination therapy is unsuitable for type 1 diabetes mellitus.
Glimatica-M1 Tablet may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal pain, diarrhea, and headache. Rare but serious adverse reactions such as lactic acidosis are also possible. Prolonged treatment may result in vitamin B12 deficiency.
Prolonged Glimatica-M1 Tablet use can indeed lead to Vitamin B12 deficiency by hindering its absorption in the gastrointestinal tract. This deficiency, if left unaddressed, may result in anemia, neurological complications such as peripheral neuropathy (manifesting as tingling, numbness in extremities, and weakness), urinary dysfunction, cognitive changes, and gait instability (ataxia). Preventive strategies proposed by some studies include supplemental Vitamin B12 intake at least annually.
Indeed, Glimatica-M1 Tablet use may result in hypoglycemia, characterized by low blood sugar. Manifestations of low blood sugar include nausea, headache, irritability, hunger, sweating, dizziness, tachycardia, and feelings of anxiety or tremor. The risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Always carry a readily available fast-acting sugar source such as glucose tablets, honey, or fruit juice.
Combining Glimatica-M1 Tablet and alcohol is unsafe. Concurrent use may cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glimatica-M1 Tablet
49
MRP 60
18% off